Science
Inhibiting Vitamin A Metabolism Pathway Enhances Cancer Immunotherapy in Preclinical Models
A metabolic byproduct of vitamin A, ATRA, suppresses cancer immunotherapy by reprogramming dendritic cells. Researchers developed KyA33 to block ATRA production, enhancing immune responses in preclinical models.